Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

een convened to offer

advice about the prospective analysis of the ENHANCE trial. (Announced

Nov. 19, 2007)

-- Reported on new study results that demonstrated that asenapine was more

effective than placebo and well tolerated in treating patients with

acute schizophrenia. (Announced Dec. 17, 2007)

-- Announced with Centocor, Inc., revision of a 1998 distribution

agreement regarding the development, commercialization and distribution

of both REMICADE (infliximab) and golimumab. (Announced Dec. 21, 2007)

-- Received priority review status from FDA for the company's New Drug

Application for sugammadex, an agent specifically designed to reverse

the effects of certain muscle relaxants used in surgery. Also announced

filing of an NDA with the Japanese Ministry of Health, Labor and

Welfare. (Announced Jan. 2, 2008, and Jan. 17, 2008, respectively)

-- Merck/Schering-Plough Pharmaceuticals announced the primary endpoint

and other results of the ENHANCE trial. Merck/Schering-Plough has

submitted an abstract on the ENHANCE trial for presentation at the

American College of Cardiology meeting, which will be held in March

2008. (Announced Jan. 14, 2008)

-- Reported top-line results of the IDEAL study, showing that sustained

virologic response was similar for the two leading combination

therapies for hepatitis C, and that fewer patients treated with both

PEGINTRON regimens relapsed after the end of treatment compared to

those receiving Pegasys and Copegus. (Announced Jan. 14, 2008)

-- Announced that Schering-Plough Chairman/CEO Fred Hassan intends to make

an open market purchase of $2 million of Schering-Plough Common Shares

with personal funds. (Announced Jan. 18, 2008)

-- With Merck, issued a release strongly objecting to mischaracterizations

of
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Eckert & Ziegler Vitalea Science (EZVS), a leading ... pharmaceutical and biotech industry, has announced that Dr. Mark ... of Director of Science & Technology. , “Mark brings ... drug metabolism and bioanalysis to EZVS in both pharma ...
(Date:1/22/2015)... (PRWEB) January 21, 2015 Cambridge Semantics, the ... technology, today announced that 2014 was a record-breaking year across ... capabilities of the Anzo Smart Data Platform and our Smart ... utilize insights from diverse data which led to record growth ...
(Date:1/22/2015)... zFlo Motion , a US leader in ... product from a new partner. STT-Systems has developed ... 15 years, with offerings in the optical-motion capture, 3D scanning, ... (inertial measurement unit), iSen, is opening eyes around the world. ...
(Date:1/22/2015)... NEW BRUNSWICK , Nueva Jersey , 22 ... Award for Biomedical Research abre hoy su llamada ... las personas cuya investigación científica ha hecho, o tiene ... de la salud humana. Las nominaciones se aceptarán hasta ...
Breaking Biology Technology:Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 2Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 3Cambridge Semantics Announces Record Results for 2014 23D Motion Capture Just Got Easy 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4
... DURHAM, N.C. Scientists drew fittingly from Roman mythology ... after the god Janus, who is usually depicted as ... years, scientists have been fascinated by the tantalizing possibilities ... display devices, sensors and many other devices. However, realizing ...
... , , , HANGZHOU, China, ... Board: CCEL), one of the largest and most established leaders in stem cell ... Biosciences, Inc. (SEB), a privately-held stem cell and genomics technology company located near ... Zhejiang Pr o vince , People,s Re ...
... , COLLEGEVILLE, Pa., Aug. 11 Wyeth ... it received notice that the action date for the U.S. Food ... License Application (BLA) for Prevnar 13(TM), (Pneumococcal 13-valent ... 2009, to December 30, 2009. In response to an FDA ...
Cached Biology Technology:Capping a two-faced particle gives duke engineers complete control 2Cryo-Cell Announces Strategic Partnership With S-Evans Biosciences, Inc. 2Cryo-Cell Announces Strategic Partnership With S-Evans Biosciences, Inc. 3Cryo-Cell Announces Strategic Partnership With S-Evans Biosciences, Inc. 4Cryo-Cell Announces Strategic Partnership With S-Evans Biosciences, Inc. 5Cryo-Cell Announces Strategic Partnership With S-Evans Biosciences, Inc. 6Wyeth Provides Regulatory Update on Prevnar 13* in the United States 2Wyeth Provides Regulatory Update on Prevnar 13* in the United States 3Wyeth Provides Regulatory Update on Prevnar 13* in the United States 4Wyeth Provides Regulatory Update on Prevnar 13* in the United States 5Wyeth Provides Regulatory Update on Prevnar 13* in the United States 6
(Date:1/22/2015)... 13, 2015 Technology Showcase, Hall E -   EyeLock ... today announced it will showcase its EyeLock ID technology integrated ... Department of Energy,s Oak Ridge National Laboratory (ORNL) ... EyeLock,s iris identity authentication technology is being used to validate ...
(Date:1/22/2015)... and POINT ROBERTS, Washington , January 20, ... leading sectors including technology and tech stocks, releases video from ... master pickpocket and security consultant Apollo Robbins . ... talks about the Wocket™ biometric smart wallet, a product of ...
(Date:1/22/2015)... EyeLock, Inc. , a market leader of iris-based identity authentication ... to the new role of Senior Vice President of Mobile ... mobile platforms and wearable solutions for EyeLock,s technologies. Gerber brings ... semiconductor industry to his role at EyeLock, with expertise in ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... trying to find ways to get more energy out of the ... and carbon dioxide and then convert it to oxygen and sugars. ... dispersed throughout the plant like that sweet corn we look ... products we use is not as efficient as we would like. ...
... omega-3 fatty acid is about to improve an American ... move biotechnology onto the average consumer,s daily radar. U.S. ... environmental impacts and increase production to feed a growing ... , Recently, the U.S. Food and Drug Administration issued ...
... BEDFORD, Mass. , March 16 ... provider of imaging and biometrics software, today announced ... Martin,s Advanced Technology Workstation (ATW).  Lockheed Martin recently ... ATWs for the Next Generation Identification (NGI) system. ...
Cached Biology News:Frogs, foam and fuel: University of Cincinnati researchers convert solar energy to sugars 2New biotech advance to add heart healthy omega-3s to US diet 2Aware Biometrics Software Provided for Advanced Technology Workstations 2Aware Biometrics Software Provided for Advanced Technology Workstations 3Aware Biometrics Software Provided for Advanced Technology Workstations 4
... a synthetic peptide whose sequence is from the C-terminal end of the ... extends from amino acids 429 to 448 of RAR*. The sequence ... - V - S - P - S - S - V ... - Q - S - P - L - L - Q ...
... is the next step in the evolution ... track system that delivers labware to multiple ... 10 times the throughput of ordinary microplate ... a variety of configurations to meet any ...
... use of small interfering RNA (siRNA) molecules ... interference,(RNAi) pathway have generated tremendous interest in ... for experimental use can be,synthesized in vitro, ... into the target cells in vitro or ...
... Varians unique collision reaction interface (CRI) ... of troublesome spectroscopic interferences. The result ... without the worry of complex multipole ... cells. And, by coupling autotuning of ...
Biology Products: